(Q36821282)

English

Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease

scientific article published on July 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

hypercholesterolemia

0 references

author name string

Feher MD

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Foxton J

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Banks D

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Lant AF

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Wray R

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

1 July 1995

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

British Heart Journal

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

74

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

14-17

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Review of European clinical experience with fenofibrate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

The value of lowering cholesterol after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Rhabdomyolysis with simvastatin use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

29 September 2017

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

27 June 2018

Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

27 June 2018

Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

27 June 2018

Combination drug therapy for familial combined hyperlipidemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=483939

5 September 2018

HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of skeletal muscle isoform of serum creatine kinase in heterozygous familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of combined bezafibrate-simvastatin appraised in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypertriglyceridemia: a contraindication to the use of bile acid binding resins

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin, nicotinic acid, and rhabdomyolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin and rhabdomyolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hypolipidemic effects of lovastatin and clofibrate alone and in combination in patients with type III hyperlipoproteinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/7662446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.74.1.14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36821282&oldid=2112442385"